Taiwan's "high-end vaccine" company backed by Tsai Ing-wen was investigated for insider trading Wang Hongwei satirized: Tsai Ing-wen going to hide again?

Source: China Taiwan Net

has developed Taiwan’s self-produced vaccine ’s high-end biotechnology company on the island and its parent company Chia have been questioned about insider trading. Finally, on December 29, Shilin Prosecutors were divided into 16 groups to seize and inspect various equipment of the company, and interviewed 18 people including the chairman of Keiya Zhang Shizhong . Ou Chaoquan paid 100,000 yuan in bond, and the other two investors suspected of insider trading paid 50,000 yuan and 100,000 yuan in bond respectively. Zhang Shizhong also ruled to pay 300,000 yuan in bond in the early morning of the 30th. In this regard, Wang Hongwei, the representative candidate of the Chinese Kuomintang in Taipei, satirized that Tsai Ing-wen, who had rushed to hold a press conference as soon as the stock price of high-end fell to the limit, will she come forward this time to make it clear, "Or should I hide again?"

Wang Hongwei He said that the high-end stock speculation has been questioned many times in the past. Compared with the stock price and trading volume in recent months this year, whenever the high-end releases good news about the company, stock will appear higher than usual Trading volume, followed by a drop in stock prices. Wang Hongwei criticized that Taiwan's financial management department transferred relevant data to the local procuratorate nine times, but it took so long for the investigation to start. "I am afraid that the evidence that can be wiped out has been destroyed long ago." There are many voices of selling high-end stocks in private. In November, three companies including Chia, chairman of Taiwan’s high-end vaccine corporation, Anji Biomedical, director of Taiwan’s Changsheng, and Taiwei Advanced, a major shareholder of Taiwan’s Zhongguang Optoelectronics, sold 10,000 yuan a day in November. shares, selling a total of 220,000 shares each. However, according to relevant regulations, important insiders such as major shareholders and directors of listed companies in Taiwan must report in advance the transfer of holdings when selling shares, but if they sell no more than 10,000 shares a day, they do not need to report. Wang Hongwei bluntly stated that these important management levels such as the chairman, directors, and major shareholders of the company sold shares without reporting them. At that time, they were questioned as stealing.

Wang Hongwei criticized that when the epidemic was severe, Tsai Ing-wen continued to disappear and rarely showed up, but on May 31 this year, high-end stocks came out to hold a press conference as soon as the limit fell. Should Tsai Ing-wen come out and explain? Or should she hide again?" (Source: China Taiwan Network )